Medication info
Mirtel Tablet 40 mg (Telmisartan)

Mirtel Tablet 40 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Samchundang Pharmaceutical Co., Ltd.
Appearance
White or almost white, double convex, round tablet
Packaging
30 tablets/box [(10 tablets/Alu-Alu)x3]
Approval status
Active

MFDS item code 201701088 · Approved 2017.02.28 · Insurance code 651204930

Summary

Main use
Treatment of essential hypertension, reduction and prevention of cardiovascular disease risk in high-risk patients
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan should be administered orally with water at a dose of 40 mg once daily, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is observed 4 ∼ 8 weeks after treatment is started. This medicine has an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: This medicine is recommended for oral administration with water at a dose of 80 mg once daily, and may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Samchundang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension, reduction and prevention of cardiovascular disease risk in high-risk patients

  • Essential hypertension
  • coronary artery disease
  • peripheral arterial disease
  • stroke
  • transient ischemic attack
  • high-risk diabetes with clinical evidence of vascular damage
  • myocardial infarction
View approved original text

This medication is used to control blood pressure in patients with essential hypertension. Additionally, it helps reduce the risk of cardiovascular disease in patients aged 55 or older with a history of coronary artery disease, peripheral arterial disease, stroke, or transient ischemic attack, or in patients with high-risk diabetes. In these patient populations, this medication plays a role in reducing the risk of myocardial infarction, stroke, and mortality due to cardiovascular disease. Therefore, it is effectively used for essential hypertension and reducing the risk of cardiovascular disease.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan should be administered orally with water at a dose of 40 mg once daily, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is observed 4 ∼ 8 weeks after treatment is started. This medicine has an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: This medicine is recommended for oral administration with water at a dose of 80 mg once daily, and may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used by individuals allergic to this medication or its ingredients, by women who are pregnant or breastfeeding, by patients with severe liver dysfunction, hereditary angioedema, or by patients with diabetes or severe kidney impairment. Caution should be exercised when prescribing this medication to elderly patients, patients with hyperkalemia or those whose potassium levels easily increase, patients with liver dysfunction, patients with heart valve disease, and patients with ischemic heart disease or cerebrovascular disorders. During treatment with this medication, various adverse reactions may occur, such as infections, blood abnormalities, allergic reactions, hypotension, gastrointestinal disorders, liver function abnormalities, muscle pain, and renal dysfunction; hence, symptoms should be carefully monitored. In particular, if symptoms of angioedema occur, the medication should be stopped immediately and healthcare personnel should be notified. Prompt action is also required if hyperkalemia or renal function deterioration is suspected. It is recommended that this medication be administered to patients with compromised kidney function while regularly monitoring potassium and creatinine levels in the blood. In patients with decreased blood volume or sodium deficiency, hypotension may occur, so conditions should be corrected before administration. Caution is needed when taking this medication with other antihypertensives as blood pressure may drop too low; potassium levels should be frequently checked when used in conjunction with certain diuretics or potassium supplements. This medication may cause dizziness or fainting during driving or operating hazardous machinery, so caution is required. Women who are pregnant or planning to become pregnant, as well as breastfeeding women, should avoid using this medication. If it must be used under unavoidable circumstances, consultation with healthcare personnel is necessary. Safety and efficacy have not been established in children under 18 years of age, therefore its use is not recommended. In the case of overdose, symptoms such as hypotension, dizziness, acute renal failure may occur, necessitating immediate assistance from healthcare personnel, and since the medication is not removed by dialysis, appropriate treatment is required based on symptoms. This medication should be kept out of reach of children, and it is crucial to maintain its sealed state until taken.

Side effects

  • Upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 82 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbance
  • liver function abnormality
  • liver dysfunction
  • increased sweating
  • pruritus
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • joint pain
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • decreased hemoglobin
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • decreased appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • palpitations
  • nausea
  • insufficient effect
  • arrhythmia
  • angioedema
  • shock
  • loss of consciousness
  • jaundice
  • symptoms resembling anaphylaxis
  • interstitial pneumonia
  • rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The recommended storage temperature is room temperature between 1 degree and 30 degrees Celsius. Proper storage helps maintain the effectiveness and safety of the medication.

Appearance and packaging

Appearance

White or almost white, double convex, round tablet

Package unit

30 tablets/box [(10 tablets/Alu-Alu)x3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.